Anaesthesia and Intensive Care最新文献

A woman in her early sixties presented to the emergency department with an altered level of consciousness and severe hypertension (blood pressure 197/111 mmHg) on a background of Grave's disease, osteoporosis and hypertension. She was intubated following prolonged seizure activity attributed to critical hyponatraemia (serum sodium 108 mmol/L). Abnormal renal function (estimated glomerular filtration rate 51 ml/min per 1.73m²) was also identified on admission. She was transferred to the intensive care unit for further investigation and management of hypertension and hyponatraemia, where she made an excellent recovery and a unifying diagnosis of bilateral renal artery stenosis was made. Renal artery stenosis has been previously described with chronic and unilateral presentations not requiring intensive care support. This case report describes the pathophysiology of this previously unreported presentation of severe symptomatic hyponatraemia and hypertension due to bilateral renal artery stenosis and the challenges faced in intensive care to determine the diagnosis.

Prekallikrein deficiency is a rare autosomal recessive coagulation disorder that prolongs the activated clotting time. Guidelines for safe intraoperative coagulation control in patients with prekallikrein deficiency undergoing endovascular aortic repair are limited. We present a case of a 70-year-old man with prekallikrein deficiency who underwent endovascular aortic repair and required intraoperative anticoagulation control. Intraoperative anticoagulation with heparin and protamine was successfully managed using the activated clotting time measurements after preoperative administration of two units of fresh frozen plasma for prekallikrein replenishment. Preoperative prekallikrein replenishment by fresh frozen plasma administration contributed to safe intraoperative anticoagulation management.

The preoperative risk score and key recommendations designed by the National Emergency Laparotomy Audit (NELA) have resulted in improved outcomes for patients undergoing emergency laparotomy. However, the recommended routine intensive care/high dependency unit (ICU) admission for high-risk patients is not always logistically possible and predictive models are needed to identify patients who will benefit. We conducted a study of patients undergoing emergency laparotomy at our tertiary hospital in Western Australia between 2018 and 2023 to identify factors that were associated with the need for ICU admission after emergency laparotomy, as defined by the requirement for a vasopressor infusion, continuous renal replacement therapy or ventilation. Of 1100 patients identified, 875 were included in the primary analysis. In multivariate analysis, the only independent predictive factors of the need for ICU therapies were the American Society of Anesthesiologists grade (P=0.017) and peak intraoperative serum lactate concentration >2 mmol/L (P=0.038). An increased NELA score was associated with mortality; however, it was not associated with the requirement for any ICU therapy (P=0.993). Although only 35.8% of high-risk patients were admitted to ICU, there was no apparent increase in adverse outcomes including mortality or unexpected ICU admission, and 27.4% of patients that were admitted to ICU received no specific therapies. This study provides a basis for the development of new predictive models for ICU admission post emergency laparotomy, and suggests the possibility that routine elective admission might not necessarily add value beyond that achieved by other NELA standards.

On 14 October 1846, Charles F Heywood, house-surgeon at the Massachusetts General Hospital, Boston, MA, USA, penned an invitation to the dentist William TG Morton to demonstrate his preparation to prevent pain during a surgical operation at the Hospital on 16 October 1846. The operation would become the first public operation performed with the aid of insensibility produced by the inhalation of sulphuric ether. From Boston, news of the discovery spread around the world-the date of this momentous operation is now celebrated as Ether Day. Although Heywood's letter is well-known from 19th century transcripts, it is apparent from examining a letter believed to be the original, now preserved in the WTG Morton papers held by the Massachusetts Historical Society, Boston, MA, USA, that these transcripts were edited before publication. A faithful transcript of Heywood's letter is published along with two images of the historic letter.

Tubeless microlaryngoscopy optimises surgical access but typically relies on total intravenous anaesthesia, commonly using propofol and remifentanil infusions. We present a difficult airway case where an unrecognised drug error during programming of an infusion pump resulted in unexpected apnoea. Open airway surgery proceeded with the use of a prophylactic cannula cricothyroidotomy using a Rapid-O2® insufflation device to provide rescue oxygenation. Furthermore, cricothyroid membrane identification failed with digital palpation but was successful with ultrasonography. While the latter is currently not considered the standard of care for preparing for front-of-neck access in a time-critical 'can't intubate, can't oxygenate' scenario, in our case it proved helpful.

Rates of misrepresenting smoking status on day of surgery varies with the clinical context. In perioperative smoking cessation trials, participants in the intervention group might be more likely to provide untruthful data about quitting when they have received substantial quit support but continued to smoke. The objective of this study was to determine misrepresentation rates of smoking status on day of surgery in mixed elective surgical populations, comparing groups offered or not offered additional cessation support. We undertook a post hoc analysis of data from three published randomised trials at a Melbourne public hospital that incorporated interventions during the wait-list period aimed at increasing smoking cessation. Participants were smokers (n = 1413) who were randomised to minimal cessation help at wait-listing (control group) or significant assistance, for example, mailed nicotine replacement (intervention group). Quit by day of surgery claims were verified by exhaled carbon monoxide (true cessation <8 parts per million). Verified cessation (>24 h) before surgery occurred in 161/1413 (11.4%) while 44/1413 (3.1%) misrepresented quitting. Continued smoking was in 1208/1413 (85.5%). Misrepresentations were higher in the intervention/offer of help groups (4.1%) than control groups (1.7%) (odds ratio (OR) 2.46, 95% confidence interval (CI) 1.17 to 5.63, P = 0.012). Offering cessation help increased quitting odds by 77%, (OR 1.77, 95% CI 1.24 to 2.52, P = 0.002). In contrast to other studies, we found group allocation in cessation trial settings had a significant effect on misrepresentation risk. The implication of this is that biochemical verification of quit status is essential in trial contexts for accurate data collection and to prevent misclassification bias.